Combination Therapy of Umbilical Cord Blood and Erythropoietin for Stroke Paients
Status:
Recruiting
Trial end date:
2021-11-02
Target enrollment:
Participant gender:
Summary
This clinical trial is a clinical trial for the evaluation of the safety and efficacy of
umbilical cord blood (UCB) therapy, UCB and erythropoietin (EPO) combination therapy in adult
stroke patients.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Bundang CHA Hospital
Collaborator:
Korea Evaluation Institute of Industrial Technology